Table 3.
Wound healing, and Rutherford class 0–3 at 1, 6, 12, 36, and 60 months
| Outcome | Total | PCCs | PBMNCs | P |
|---|---|---|---|---|
| Complete wound healing, n (%) | ||||
| At enrollment | 0/145 | 0/71 | 0/74 | 1.000 |
| At 1 months | 13/145 | 6/71 | 7/74 | .846 |
| At 6 months | 85/140 | 40/69 | 45/71 | .512 |
| At 12 months | 111/128 | 58/68 | 53/60 | .613 |
| At 36 months | 86/90 | 50/51 | 36/39 | .880 |
| At 60 months | 47/47 | 34/34 | 13/13 | .292 |
| Rutherford class 0–3, n (%) | ||||
| At enrollment | 0/160 | 0/82 | 0/78 | 1.000 |
| At 1 month | 19/160 | 10/82 | 9/78 | .898 |
| At 6 months | 89/153 | 43/78 | 46/75 | .437 |
| At 12 months | 120/139 | 64/77 | 56/62 | .219 |
| At 36 months | 87/93 | 50/53 | 37/40 | 1.000 |
| At 60 months | 47/48 | 34/35 | 13/13 | 1.000 |
PCCs purified CD34+ cells, PBMNCs peripheral blood mononuclear cells